|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008, Cancer incidence and
mortality worldwide. (IARC CancerBase No. 10. [Internet]).
International Agency for Research on Cancer; Lyon, France: 2010,
Available from http://globocan.iarc.fr.
Accessed May 6, 2012.
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Burger M, Catto JW, Dalbagni G, Grossman
HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C,
Shariat S, et al: Epidemiology and risk factors of urothelial
bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Letašiová S, Medve'ová A, Šovčíková A,
Dušinská M, Volkovová K, Mosoiu C and Bartonová A: Bladder cancer,
a review of the environmental risk factors. Environ Health.
11(Suppl 1): S112012. View Article : Google Scholar
|
|
7
|
Boffetta P: Tobacco smoking and risk of
bladder cancer. Scand J Urol Nephrol Suppl. 218:45–54. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeegers MP, Tan FE, Dorant E and van Den
Brandt PA: The impact of characteristics of cigarette smoking on
urinary tract cancer risk: A meta-analysis of epidemiologic
studies. Cancer. 89:630–639. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freedman ND, Silverman DT, Hollenbeck AR,
Schatzkin A and Abnet CC: Association between smoking and risk of
bladder cancer among men and women. JAMA. 306:737–745. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hecht SS: Tobacco smoke carcinogens and
lung cancer. J Natl Cancer Inst. 91:1194–1210. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Phillips DH: Smoking-related DNA and
protein adducts in human tissues. Carcinogenesis. 23:1979–2004.
2002. View Article : Google Scholar
|
|
12
|
Hecht SS: Tobacco carcinogens, their
biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3:733–744.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sobus SL and Warren GW: The biologic
effects of cigarette smoke on cancer cells. Cancer. 120:3617–3626.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schaal C and Chellappan SP:
Nicotine-mediated cell proliferation and tumor progression in
smoking-related cancers. Mol Cancer Res. 12:14–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cardinale A, Nastrucci C, Cesario A and
Russo P: Nicotine: Specific role in angiogenesis, proliferation and
apoptosis. Crit Rev Toxicol. 42:68–89. 2012. View Article : Google Scholar
|
|
16
|
Ho YS, Chen CH, Wang YJ, Pestell RG,
Albanese C, Chen RJ, Chang MC, Jeng JH, Lin SY and Liang YC:
Tobacco-specific carcinogen
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell
proliferation in normal human bronchial epithelial cells through
NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl
Pharmacol. 205:133–148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin VY, Jin HC, Ng EK, Yu J, Leung WK,
Cho CH and Sung JJ: Nicotine and
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce
cyclooxygenase-2 activity in human gastric cancer cells:
Involvement of nicotinic acetylcholine receptor (nAChR) and
beta-adrenergic receptor signaling pathways. Toxicol Appl
Pharmacol. 233:254–261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Norton JD: ID helix-loop-helix proteins in
cell growth, differentiation and tumorigenesis. J Cell Sci.
113:3897–3905. 2000.PubMed/NCBI
|
|
19
|
Aggarwal BB: Nuclear factor-kappaB: The
enemy within. Cancer Cell. 6:203–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Orlowski RZ and Baldwin AS Jr: NF-kappaB
as a therapeutic target in cancer. Trends Mol Med. 8:385–389. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bassères DS and Baldwin AS: Nuclear
factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic
initiation and progression. Oncogene. 25:6817–6830. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
23
|
Lin Y, Bai L, Chen W and Xu S: The
NF-kappaB activation pathways, emerging molecular targets for
cancer prevention and therapy. Expert Opin Ther Targets. 14:45–55.
2010. View Article : Google Scholar
|
|
24
|
Dobrovolskaia MA and Kozlov SV:
Inflammation and cancer: When NF-kappaB amalgamates the perilous
partnership. Curr Cancer Drug Targets. 5:325–344. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gál K1, Cseh A, Szalay B, Rusai K, Vannay
A, Lukácsovits J, Heemann U, Szabó AJ, Losonczy G, Tamási L and
Müller V: Effect of cigarette smoke and dexamethasone on Hsp72
system of alveolar epithelial cells. Cell Stress Chaperones.
16:369–378. 2011. View Article : Google Scholar :
|
|
27
|
Alguacil J, Kogevinas M, Silverman DT,
Malats N, Real FX, García-Closas M, Tardón A, Rivas M, Torà M,
García-Closas R, et al: Urinary pH, cigarette smoking and bladder
cancer risk. Carcinogenesis. 32:843–847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baldi A, De Luca A, Esposito V, Campioni
M, Spugnini EP and Citro G: Tumor suppressors and cell-cycle
proteins in lung cancer. Patholog Res Int.
2011:6050422011.PubMed/NCBI
|
|
29
|
Crawford JM: The origins of bladder
cancer. Lab Invest. 88:686–693. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Xie W, Xie C, Huang C, Zhu J, Liang
Z, Deng F, Zhu M, Zhu W, Wu R, et al: Curcumin modulates
miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7
breast cancer cell proliferation. Phytother Res. 28:1553–1560.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bishop RK, Valle OC and Spencer JV: Human
cytomegalovirus interleukin-10 promotes proliferation and migration
of MCF-7 breast cancer cells. Cancer Cell Microenviron.
2:e6782015.PubMed/NCBI
|
|
32
|
Li T, Song T, Ni L, Yang G, Song X, Wu L,
Liu B and Liu C: The p-ERK-p-c-Jun-cyclinD1 pathway is involved in
proliferation of smooth muscle cells after exposure to cigarette
smoke extract. Biochem Biophys Res Commun. 453:316–320. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao J, Zhao L, Zhao Q, Zhao Y, Sun Y,
Zhang Y, Miao H, You QD, Hu R and Guo QL: NF-κB and Nrf2 signaling
pathways contribute to wogonin-mediated inhibition of
inflammation-associated colorectal carcinogenesis. Cell Death Dis.
5:e12832014. View Article : Google Scholar
|
|
36
|
Alvira CM: Nuclear factor-kappa-B
signaling in lung development and disease: One pathway, numerous
functions. Birth Defects Res A Clin Mol Teratol. 100:202–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Yan M, Wang Z, Jing S, Li Y, Liu G,
Yu J and Fan Z: Effects of canonical NF-κB signaling pathway on the
proliferation and odonto/osteogenic differentiation of human stem
cells from apical papilla. Biomed Res Int. 2014:3196512014.
|
|
38
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132.
2012.PubMed/NCBI
|
|
39
|
Helisch A, Förster GJ, Reber H, Buchholz
HG, Arnold R, Göke B, Weber MM, Wiedenmann B, Pauwels S, Haus U, et
al: Pre-therapeutic dosimetry and biodistribution of
86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in
patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol
Imaging. 31:1386–1392. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim HJ, Hawke N and Baldwin AS: NF-kappaB
and IKK as therapeutic targets in cancer. Cell Death Differ.
13:738–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang XY, Xu YJ, Liu XS and Zhang ZX:
Cigarette smoke extract promotes proliferation of airway smooth
muscle cells in asthmatic rats via regulating cyclin D1 expression.
Chin Med J (Engl). 123:1709–1714. 2010.
|
|
42
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hinz M, Krappmann D, Eichten A, Heder A,
Scheidereit C and Strauss M: NF-kappaB function in growth control:
Regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
Mol Cell Biol. 19:2690–2698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Villar HO, Uyeno ET, Toll L, Polgar W,
Davies MF and Loew GH: Molecular determinants of benzodiazepine
receptor affinities and anticonvulsant activities. Mol Pharmacol.
36:589–600. 1989.PubMed/NCBI
|
|
45
|
Morgan RG, Ives SJ, Lesniewski LA, Cawthon
RM, Andtbacka RH, Noyes RD, Richardson RS and Donato AJ:
Age-related telomere uncapping is associated with cellular
senescence and inflammation independent of telomere shortening in
human arteries. Am J Physiol Heart Circ Physiol. 305:H251–H258.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chung S, Sundar IK, Hwang JW, Yull FE,
Blackwell TS, Kinnula VL, Bulger M, Yao H and Rahman I: NF-κB
inducing kinase, NIK mediates cigarette smoke/TNFα-induced histone
acetylation and inflammation through differential activation of
IKKs. PLoS One. 6:e234882011. View Article : Google Scholar
|
